Congress funds early-warning disease surveillance through wastewater testing

What it does

This bill directs the CDC to award grants and contracts to state, local, and tribal health departments to establish or improve wastewater surveillance systems that detect infectious diseases early for emergency preparedness. Eligible entities (health departments and their public-private partnerships) receive federal funding to sample wastewater, analyze it for pathogens, share data publicly, and sustain these monitoring activities; the CDC will issue technical guidance and maintain a public database of findings.

Why we flagged it

The bill's operative mechanism is a straightforward federal grant program to build and sustain wastewater surveillance capacity at the local and state level. It is a public-health infrastructure measure, not a regulatory carve-out, tax provision, or private subsidy.

What the text implies

• Wastewater surveillance data could reveal disease prevalence in specific neighborhoods or facilities, potentially exposing vulnerable populations or stigmatized communities to public health scrutiny or social stigma if data is not carefully anonymized or contextualized.
• The bill requires public data access and comparison across recipients, which may create pressure on under-resourced health departments to participate or risk appearing less transparent, potentially widening disparities in surveillance capacity.
• Wastewater surveillance can detect drug metabolites and other substances beyond infectious diseases; the bill does not explicitly restrict use of collected samples or data to infectious disease monitoring, creating potential for scope creep.
• The 'and for other purposes' language in the title, while standard, leaves room for future regulatory expansion of the program's scope without explicit congressional reauthorization.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens gain early-warning capacity for disease outbreaks through a low-cost, non-invasive surveillance method that does not require individual testing or medical records. The bill mandates public data access and transparency, strengthening accountability and enabling communities to prepare for health emergencies.

Who stands to gain

• state and local health departments
• wastewater testing laboratories and service providers
• public health research institutions
• environmental testing and analysis contractors

Named in the bill

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), State health departments, Tribal health departments, Local health departments, Public Health Service Act

Where it stands

5 cosponsors: 2 Democrats, 2 Republicans, 1 Independents.

• Mar 11, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 11, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

4 lobbying clients named this bill on 4 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $310,000 in lobbying spend. A filing names 18 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 72% of bills with at least one filing.

Tim Scott, the sponsor, reported $214,300 in PAC receipts in the 2026 cycle.

• Wastewater Action Alliance — $140,000 on 1 filing
• Boyd Gaming Corporation — $60,000 on 1 filing
• Boyd Gaming Corporation — $60,000 on 1 filing
• American Society for Microbiology — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.